News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioMarin Pharmaceutical Inc. (BMRN) Denies Compassionate Use to Cancer Patient



9/9/2013 8:32:50 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BioMarin Pharmaceutical in San Rafael has denied a request for immediate access to an experimental drug treatment for a 45-year-old Texas woman with advanced ovarian cancer. But Rep. Jared Huffman, D-San Rafael, who has gotten involved in the case due to a flood of calls to his office, said Friday that BioMarin has told him it is exploring the possibility of including the woman, Andrea Sloan, in a new clinical trial with the drug: poly ADP-ribose polymerase (PARP) inhibitor BMN 673. "We're talking about a matter weeks," Huffman said. "Possibly 40 days. I'm looking into doing better than that."

Help employers find you! Check out all the jobs and post your resume.

Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES